Cullinan Oncology is a leading biopharmaceutical company based in Cambridge, MA, dedicated to revolutionizing cancer treatment by creating new standards of care for patients. With a robust and diversified pipeline, they take a unique approach to research and development, identifying high-impact targets and pursuing the best modality to develop transformative therapeutics across various cancer indications.
Driven by innovation without borders, Cullinan Oncology leverages scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and prioritize patient benefit. Through strategic collaborations with academic and industry partners, they advance promising clinic-ready cancer therapies, aiming to make a significant impact in the field of oncology.
Generated from the website